The Journal of Liquid Biopsy aims to cover the research insight into the molecular pathways analyzed by using liquid biopsy-based biomarkers (cfDNA, ctDNA, miRNA, CTC, extracellular vesicles, protein, etc.) and their relative clinical implication.
An integrated approach that includes molecular findings, technical aspects, and clinical data is encouraged to provide a comprehensive view of liquid biopsy.
The editors welcome papers that:
- Clarify molecular mechanisms behind analytes relapse in torrent blood;
- Provide a clinical interpretation of molecular insights regarding the implementation of liquid biopsy-related biomarkers;
- Identify technical issues for liquid biopsy-related biomarkers identification, detection, and analysis;
- Promote novel technical strategies capable of successfully evaluating the molecular landscape of liquid biopsy-related biomarkers.
Volume 1: September 2023
Volume 2: December 2023
Volume 3: March 2024
Volume 4: June 2024
Volume 5: September 2024